Your browser doesn't support javascript.
loading
Prognostic impact of genomic instability in colorectal cancer.
Hveem, T S; Merok, M A; Pretorius, M E; Novelli, M; Bævre, M S; Sjo, O H; Clinch, N; Liestøl, K; Svindland, A; Lothe, R A; Nesbakken, A; Danielsen, H E.
Afiliação
  • Hveem TS; 1] Institute for Cancer Genetics and Informatics, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway [3] Department of Informatics, University of Oslo, PO Box 1080 Blindern, 0316 Oslo, Norway.
  • Merok MA; 1] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, PO Box 4953 Nydalen, 0424 Oslo, Norway [3] Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blinde
  • Pretorius ME; 1] Institute for Cancer Genetics and Informatics, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Novelli M; 1] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Department of Pathology, University College Hospital, London WC1E 6JJ, UK.
  • Bævre MS; 1] Institute for Cancer Genetics and Informatics, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Sjo OH; Department of Gastrointestinal Surgery, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Clinch N; Institute for Cancer Genetics and Informatics, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Liestøl K; 1] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Department of Informatics, University of Oslo, PO Box 1080 Blindern, 0316 Oslo, Norway.
  • Svindland A; 1] Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, 0318 Oslo, Norway [2] Department of Pathology, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Lothe RA; 1] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, PO Box 4953 Nydalen, 0424 Oslo, Norway [3] Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blinde
  • Nesbakken A; 1] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, 0318 Oslo, Norway [3] Department of Gastrointestinal Surgery, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway.
  • Danielsen HE; 1] Institute for Cancer Genetics and Informatics, Oslo University Hospital, PO Box 4950 Nydalen, 0424 Oslo, Norway [2] Centre for Cancer Biomedicine, University of Oslo, PO Box 4950 Nydalen, 0424 Oslo, Norway [3] Department of Informatics, University of Oslo, PO Box 1080 Blindern, 0316 Oslo, Norway
Br J Cancer ; 110(8): 2159-64, 2014 Apr 15.
Article em En | MEDLINE | ID: mdl-24642618

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias Colorretais / Instabilidade de Microssatélites Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Neoplasias Colorretais / Instabilidade de Microssatélites Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Noruega